Targeted protein degradation (TPD) offers a promising approach for treating neurodegenerative diseases by selectively degrading disease-linked proteins. Despite challenges in delivery and stability, advancements in TPD technologies show potential in addressing diseases like Alzheimer’s, Parkinson’s, and Huntington’s.
Get this White Paper and have details about:
For research use only. Not for use in diagnostic procedures.
Targeted protein degradation: a novel therapeutic strategy for neurodegenerative diseases